Arcturus Therapeutics News

Optimistic Buy Rating for Arcturus Therapeutics Amid Strong Kostaive Vaccine Market Prospects in Japan

TipRanksMar 26 07:15 ET

Arcturus Therapeutics Analyst Ratings

BenzingaMar 20 06:42 ET

Arcturus Therapeutics Analyst Ratings

BenzingaMar 11 07:50 ET

Analysts Offer Insights on Healthcare Companies: Applied Therapeutics (APLT), Xeris Pharmaceuticals (XERS) and Arcturus Therapeutics (ARCT)

TipRanksMar 11 00:40 ET

Wells Fargo Adjusts Price Target on Arcturus Therapeutics Holdings to $58 From $45, Maintains Overweight Rating

MT NewswiresMar 8 09:53 ET

Arcturus Therapeutics Analyst Ratings

BenzingaMar 8 07:48 ET

Arcturus Therapeutics (ARCT) Gets a Buy From Piper Sandler

TipRanksMar 8 07:46 ET

Analysts Offer Insights on Healthcare Companies: Cigna (CI) and Arcturus Therapeutics (ARCT)

TipRanksMar 8 05:50 ET

Arcturus Therapeutics Analyst Ratings

BenzingaFeb 8 11:03 ET

Analysts Conflicted on These Healthcare Names: McKesson (MCK), Arcturus Therapeutics (ARCT) and Neurocrine (NBIX)

TipRanksFeb 8 06:02 ET

Buy Rating for Arcturus Therapeutics Amid Promising Vaccine Developments and Cost Advantages

TipRanksJan 13 10:15 ET

Piper Sandler Remains a Buy on Arcturus Therapeutics (ARCT)

TipRanksJan 10 07:18 ET

Arcturus Therapeutics Analyst Ratings

BenzingaDec 13, 2023 04:34 ET

Buy Rating for Arcturus Therapeutics: ARCT-154's Global Regulatory Success and Market Potential

TipRanksNov 29, 2023 05:19 ET

HC Wainwright & Co. Reiterates Buy on Arcturus Therapeutics, Maintains $51 Price Target

BenzingaNov 28, 2023 07:22 ET

Arcturus Therapeutics Analyst Ratings

BenzingaNov 28, 2023 07:21 ET

Analysts Offer Insights on Healthcare Companies: Arcturus Therapeutics (ARCT) and Alcon (ALC)

TipRanksNov 16, 2023 05:50 ET

HC Wainwright & Co. Reiterates Buy on Arcturus Therapeutics, Maintains $51 Price Target

BenzingaNov 15, 2023 10:37 ET

Arcturus Therapeutics Analyst Ratings

BenzingaNov 15, 2023 10:34 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: 60 Degrees Pharmaceuticals, Inc. (SXTP), Arcturus Therapeutics (ARCT) and Intercure (INCR)

TipRanksNov 15, 2023 10:04 ET